AI-Driven Oxygen Therapeutic Systems for Enhanced Glioblastoma Treatment

A novel, integrated system combining oxygen therapeutics with AI, IoT, blockchain, and machine learning to optimize glioblastoma treatment outcomes, enhance patient care, and improve data management.

The original patent disclosed the use of oxygen therapeutics in combination with repeated administrations of chemotherapy medications and/or radiation therapy. However, it did not address the limitations of treatment scheduling, patient data management, and personalized treatment planning. The new inventive concept addresses these limitations by integrating oxygen therapeutics with advanced technologies to create a more effective and efficient treatment system.

The AI-driven oxygen therapeutic system comprises a radiotherapy module, a chemotherapy module, and an oxygen therapeutic module, which are integrated with an AI-powered predictive analytics module, a blockchain-based data management system, and a wearable IoT device. The system optimizes treatment schedules based on patient response data, securely stores and tracks patient treatment data and outcomes, and enables real-time monitoring of patient vital signs and treatment response. The oxygen therapeutic module administers a water emulsion of perfluoropentane, which enhances the effectiveness of radiotherapy and chemotherapy. The system also utilizes machine learning algorithms to analyze patient medical imaging data and identify optimal treatment strategies.

The new claims introduce the integration of oxygen therapeutics with AI, IoT, blockchain, and machine learning technologies, which is not obvious from the original patent. The inventive concept's novelty lies in the synergistic combination of these technologies to create a more powerful and effective treatment system.

Alternative embodiments of the inventive concept could include the use of different oxygen therapeutic agents, varying the dosage and administration schedule of the oxygen therapeutic, or incorporating additional advanced technologies such as robotics or virtual reality. Variations could also include the development of specific systems for different types of cancer or medical conditions.

The AI-driven oxygen therapeutic system has significant commercial potential in the healthcare industry, particularly in the fields of oncology and radiation therapy. The system could be marketed to hospitals, cancer centers, and research institutions, and could also be used in clinical trials and research studies.